PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443359
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1443359
Radiosurgery and Radiotherapy Robotics Market size was valued at USD 3,984.5 Million in 2023, expanding at a CAGR of 4.5% from 2024 to 2032.
Radiosurgery and Radiotherapy Robotics are innovative methods in the field of radiation oncology that utilize robotic systems to deliver precise radiation therapy treatments to patients. These technologies are transforming the way treatments are administered by improving accuracy, efficiency, and patient comfort. The radiosurgery technique involves the precise delivery of highly focused radiation beams to target tumors or abnormalities in the body. On the other hand, radiotherapy robotics utilizes robotic systems to administer radiation therapy with exceptional precision. Both of these approaches represent cutting-edge advancements in oncology, providing patients with highly effective and targeted treatments for cancer and other medical conditions. With the advancements in technology, these systems offer reproducibility in patient positioning and the ability to deliver radiation from various directions while synchronizing with the patient's respiration-induced target motion. This technology is now being proposed as a new local treatment option that can be completed in less than one week, showing promising results.
Radiosurgery and Radiotherapy Robotics Market- Market Dynamics
Rising Medical Problems leading to surgical procedures is anticipated to dominate the growth of market
Radiosurgery and Radiotherapy Robotics offer patients minimally invasive or non-invasive treatment options, which in turn reduce the necessity for traditional open surgeries. As a result, patients experience shorter recovery times, less pain, and a decreased risk of complications. The American Society of Plastic Surgeons (ASPS) has reported a 2 percent increase in cosmetic surgeries in 2017 compared to the previous year. In the United States alone, there were 17.5 million surgical and minimally invasive cosmetic procedures performed last year, as indicated by the annual plastic surgery procedural statistics. Notably, body shaping and minimally invasive procedures have witnessed a significant surge in popularity. Moreover, investments in healthcare infrastructure, particularly in emerging markets, are creating opportunities for the expansion of the Radiosurgery and Radiotherapy Robotics market. However, it is important to note that market growth may be hindered by reimbursement policies and coverage.
Radiosurgery and Radiotherapy Robotics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032)
Based on Type segmentation, X-ray segment was predicted to show maximum market share in the year 2023
Based on End-User segmentation, Hospital was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
The Global Radiosurgery and Radiotherapy Robotics Market is segmented on the basis of Type, End-User, and Region.
The market is divided into three categories based on Type: X-ray Based, Gamma-ray Based and Proton-beam Based. The market is predominantly dominated by the X-ray segment. X-ray imaging, which is based on X-rays, offers exceptional visualization of tumors and the surrounding anatomy in real-time during treatment. This advanced technology enables precise targeting of tumors, ensuring that radiation is delivered with utmost accuracy to the intended area while minimizing damage to healthy tissues.
The market is divided into two categories based on End-user: Hospital, Clinic and Other. The market is largely dominated by the hospital segment. Hospitals are progressively integrating robotic systems into their radiotherapy and radiosurgery procedures. These advanced platforms provide enhanced precision, accuracy, and flexibility when administering radiation therapy to specific tumors, all while reducing harm to nearby healthy tissues.
Radiosurgery and Radiotherapy Robotics Market- Geographical Insights
Geographically, this market spans across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further segmented by countries contributing to business activities. North America is expected to lead the market growth, driven by the increasing awareness of cancer-related diseases and the adoption of minimally invasive surgeries. The incidence of cancer in North America is on the rise, resulting in a higher demand for advanced treatment options. Radiosurgery and Radiotherapy Robotics provide precise and targeted treatment alternatives to traditional surgery, attracting patients looking for less invasive approaches with potentially fewer side effects. According to the American Cancer Society, it is estimated that there will be approximately 1.9 million new cancer cases diagnosed and 609,360 cancer-related deaths in the United States in 2022. Europe is the second largest region for market growth, attributed to the growing demand for advanced treatments.
The market for Radiosurgery and Radiotherapy Robotics is influenced by various factors, including the rising incidence of cancer, technological progress, increased healthcare spending, and a growing understanding of the advantages of robotic-assisted therapies. As the industry progresses, competition among major players is expected to intensify, resulting in greater innovation and strategic collaborations to establish a competitive advantage in this rapidly expanding field. Companies are engaged in fierce competition to develop and introduce new features and capabilities in their radiosurgery and radiotherapy systems. This encompasses enhancements in robotic accuracy, imaging technology, treatment planning software, and integration with other medical technologies. Competitors are working to broaden their product offerings to meet a wide range of clinical requirements and applications. This involves providing various types of robotic systems, such as linear accelerators, gamma knife systems, and proton therapy solutions, as well as offering options for both radiosurgery and radiotherapy treatments.
In January 2024 - Accuray Incorporated has recently announced that the Providence Swedish Radiosurgery Center in Seattle, Washington is expanding its cancer treatment capabilities by acquiring the latest generation CyberKnife S7 System. This marks the second purchase of a CyberKnife radiation delivery device by the hospital.
GLOBAL RADIOSURGERY AND RADIOTHERAPY ROBOTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Accuray
Brainlab
Varian Medical Systems
Elekta
Best Theratronics
Huiheng Medical
Masep Medical Science
Technology
Development
Neusoft Medical Systems
Viewray
Zhuhai Hokai Medical Instruments
Others